Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population

Background: The new finding of the heterogeneous distribution of BRAFV600E mutation in primary papillary thyroid carcinoma suggested the percentage of BRAFV600E alleles should be taken into consideration when evaluating its association with clinicopathological features of papillary thyroid carcinoma. The aim of this study was to detect both the presence and the percentage of BRAFV600E alleles in fine-needle aspiration biopsy samples and to assess its association with clinicopathological characteristics of papillary thyroid carcinoma in a Chinese population. Materials and methods: Fine needle aspiration samples were collected in a total of 182 patients (132 conventional papillary thyroid carcinomas and 50 goiters). The associations of the presence and percentage of BRAFV600E alleles genotyped by pyrosequencing with clinicopathological characteristics were evaluated in papillary thyroid carcinomas. Results: 80 (60.61%) of papillary thyroid carcinomas exhibited BRAFV600E mutation in a range of 7.7% to 46.3% of the total BRAF alleles. The presence of BRAFV600E mutation was significantly associated with extrathyroidal invasion. There was no significant difference between the presence of BRAFV600E mutation and other clinicopathological features. It was not found that the significant relationship between percentage of BRAFV600E alleles and clinicopathological characteristics. Conclusion: We concluded that the presence of BRAFV600E could be preoperatively predictive of extrathyroidal invasion in a Chinese population.